Overview
We aim to clarify the relationship between sleep hygiene and the onset of sarcopenia or cognitive dysfunction using sleep time, arousal, and sleep quality as indicators in COPD or IPF patients, and clarify the effects of sleep hygiene on disease progression and life prognosis.
Description
Chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) have been reported to be associated with a high rate of sleep-related disorders such as insomnia, sleep-related hypoventilation, and sleep apnea syndrome.Sleep-related disorders cause symptoms such as daytime sleepiness, decreased ADL, and depression, which causes cognitive dysfunction. Both COPD and IPF have been reported to be associated with cognitive dysfunction. Recently, it has been focused on the relationship between sleep-related disorders and sarcopenia. The relationship between sleep hygiene, cognitive dysfunction, and sarcopenia in the patients with COPD or IPF is not well understood.
Eligibility
Inclusion Criteria:
- Subjects with COPD or IPF.
Exclusion Criteria:
- Subjects who have been hospitalized for exacerbation of respiratory failure within 1 month of study participation
- Subjects who have already been diagnosed with sarcopenia or cognitive dysfunction
- Subjects receiving long-term oxygen therapy (LTOT) or non-invasive ventilation therapy (NIV)
- Subjects with obstructive sleep apnea who are indicated for continuous positive airway pressure (CPAP)
- Subjects with severe complications such as cardiovascular disease, liver disease, renal disease, malignancy, and neurological disease.